Skip to main content
Premium Trial:

Request an Annual Quote

Paracel and Lion Partner to Co-Market Integrated BlastMachine/BioScout Product


Lion Bioscience and Celera Genomics’ Paracel division are partnering to integrate Lion’s software with Paracel’s accelerated bioinformatics hardware, the companies told BioInform last week.

The companies have nearly completed the integration of Lion’s BioScout sequence analysis and characterization software with BlastMachine and are ready to release the combined product to customers, said Shi-Ping Hsu, general manager of Paracel.

The project is the first in a series of integration projects that Paracel is planning with other bioinformatics software providers, said Joe Borkowski, Paracel’s director of marketing.

The companies have agreed to co-market each other’s products as part of the deal. Financial details were not disclosed.

BioScout currently relies on Blast as part of its analysis pipeline, but the unmodified Blast algorithm currently slows the process considerably, Lion said. By integrating the accelerated BlastMachine system into the software, BioScout customers who have Paracel equipment will see a significant speed-up in the analysis process, according to the companies.

Borkowski said the time saving would depend on the type of Paracel system used. Speed scales linearly with the number of processors, he said, which generally range from 16 to 48 but can go higher.

Additionally, database updating and indexing features included in BioScout will manage database resources in the integrated product.

Paracel said Lion approached them after the release of BlastMachine to discuss options to speed the Blast stage of the BioScout pipeline.

The two companies are in talks regarding “other opportunities,” Hsu said, but was unable to disclose further details.

“They have a real product and we do too, so there’s a lot of opportunity there,” Hsu said.

— BT

Filed under

The Scan

Shape of Them All

According to BBC News, researchers have developed a protein structure database that includes much of the human proteome.

For Flu and More

The Wall Street Journal reports that several vaccine developers are working on mRNA-based vaccines for influenza.

To Boost Women

China's Ministry of Science and Technology aims to boost the number of female researchers through a new policy, reports the South China Morning Post.

Science Papers Describe Approach to Predict Chemotherapeutic Response, Role of Transcriptional Noise

In Science this week: neural network to predict chemotherapeutic response in cancer patients, and more.